Cargando…

Heparin or nonheparin anticoagulants for VITT

Detalles Bibliográficos
Autor principal:	Arnold, Donald M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. 2022
Materias:	Platelets and Thrombopoiesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181564/ https://www.ncbi.nlm.nih.gov/pubmed/35679072 http://dx.doi.org/10.1182/blood.2022016423

Ejemplares similares

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
por: Singh, Anurag, et al.
Publicado: (2022)

Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
por: Li, Na, et al.
Publicado: (2021)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
por: Kaur, Manraj N., et al.
Publicado: (2022)

Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
por: Norris, Peter A. A., et al.
Publicado: (2023)

Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies
por: Lynch, Donald R., et al.
Publicado: (2022)

Evans syndrome in adults: an observational multicenter study
por: Fattizzo, Bruno, et al.
Publicado: (2021)

COVID-19 concerns aggregate around platelets
por: Battinelli, Elisabeth M.
Publicado: (2020)

Characterization of the human platelet N- and O-glycome upon storage using tandem mass spectrometry
por: Rosenbalm, Katelyn E., et al.
Publicado: (2023)

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
por: Acosta-Medina, Aldo A., et al.
Publicado: (2022)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Impaired microtubule dynamics contribute to microthrombocytopenia in RhoB-deficient mice
por: Englert, Maximilian, et al.
Publicado: (2022)

Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry
por: Bowers, Charles, et al.
Publicado: (2021)

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
por: Broome, Catherine M., et al.
Publicado: (2022)

High-throughput microfluidic blood testing to phenotype genetically linked platelet disorders: an aid to diagnosis
por: Fernandez, Delia I., et al.
Publicado: (2023)

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2020)

Multiparameter phenotyping of platelet reactivity for stratification of human cohorts
por: Dunster, Joanne L., et al.
Publicado: (2021)

The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
por: Senis, Yotis A., et al.
Publicado: (2009)

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
por: Bye, Alexander P., et al.
Publicado: (2021)

Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon
por: Martyanov, Alexey A., et al.
Publicado: (2023)

COVID-19 vaccination in patients with immune thrombocytopenia
por: Visser, Chantal, et al.
Publicado: (2022)

Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2022)

Expanding the genetic spectrum of TUBB1-related thrombocytopenia
por: Palma-Barqueros, Verónica, et al.
Publicado: (2021)

G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1
por: Downes, Kate, et al.
Publicado: (2022)

Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19
por: Zlamal, Jan, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022)

The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production
por: Heazlewood, Shen Y., et al.
Publicado: (2022)

Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19
por: Garcia, Cédric, et al.
Publicado: (2022)

Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
por: Kemble, Samuel, et al.
Publicado: (2022)

Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC
por: Kasirer-Friede, Ana, et al.
Publicado: (2022)

Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP
por: Shao, Bojing, et al.
Publicado: (2022)

Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
por: Puhm, Florian, et al.
Publicado: (2022)

A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD
por: Bury, Loredana, et al.
Publicado: (2022)

Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
por: Gostynska, Sandra, et al.
Publicado: (2022)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2022)

CPT2 K79 acetylation regulates platelet life span
por: Fan, Xuemei, et al.
Publicado: (2022)

Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency
por: Jalagadugula, Gauthami, et al.
Publicado: (2022)

Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
por: Palma-Barqueros, Verónica, et al.
Publicado: (2022)

Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans
por: Gnatenko, Dmitri V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j374f77ht4fra40pum83td4oln